$MRK News 10 Nasdaq stocks with returns of at least

New Post Public Reply Private Reply Replies (0) Message Board

Sep 21, 2014 at 1:00 PM

$MRK News

10 Nasdaq stocks with returns of at least 240% in 2014 5:38 p.m. Sept. 11, 2014 - Philip van Doorn
FDA approves Merck's new-kind of cancer drug 2:57 p.m. Sept. 4, 2014 - MarketWatch.com
Merck rises 1.2% to lead Dow gainers 9:32 a.m. Aug. 13, 2014 - MarketWatch
Newscast: 20 firms with fat profits pay no taxes 5:44 a.m. Aug. 13, 2014 - MarketWatch
Merck net falls 4%; confirms full-year outlook 2:30 a.m. Aug. 13, 2014 - MarketWatch.com
Australia's CSL considers bigger stock buyback 7:35 p.m. Aug. 12, 2014 - MarketWatch.com
Zoetis narrows full-year earnings guidance 8:12 a.m. Aug. 5, 2014 - MarketWatch.com
Video chat: How have corporate earnings done so far? 12:51 p.m. July 31, 2014 - blogs.marketwatch.com
Updates, advisories and surprises 9:01 p.m. July 29, 2014 - MarketWatch
U.S. stocks end choppy trade lower 4:16 p.m. July 29, 2014 - Carla Mozee
Herbalife sinks on disappointing results; Darden gains 3:16 p.m. July 29, 2014 - Angela Johnson
Why short-sellers are winning right now and going big against Ackman's 'deathblow' 9:03 a.m. July 29, 2014 - blogs.marketwatch.com
Newscast: Wall Street may gain ground 7:35 a.m. July 29, 2014 - MarketWatch
Merck profit up on one-time gain, lower costs 7:26 a.m. July 29, 2014 - MarketWatch.com
Merck shares rise in premarket trade as profit, sales beat forecasts 7:12 a.m. July 29, 2014 - Tomi Kilgore
Merck full-year adj. 2014 EPS target $3.43-$3.53 vs. FirstCall consensus $3.48 7:00 a.m. July 29, 2014 - Tomi Kilgore
Merck Q2 FactSet sales consensus $10.59 bln 6:59 a.m. July 29, 2014 - Tomi Kilgore
Merck Q2 sales $10.934 bln vs. $11.01 bln a year ago 6:59 a.m. July 29, 2014 - Tomi Kilgore
Merck Q2 EPS 68 cents vs. 30 cents a year ago 6:58 a.m. July 29, 2014 - Tomi Kilgore
Merck Q2 adj. EPS 85 cents vs. First Call EPS consensus 81 cents 6:58 a.m. July 29, 2014 - Tomi Kilgore

Unilife: A Medical Device Company Poised For Major Upside On New Revenue Streams 11:38 a.m. Sept. 19, 2014 - Seeking Alpha
Dow 30 Stock Roundup: Boeing to Receive $4.2B Contract from NASA, Cisco to Acquire Metacloud - Analyst Blog 10:40 a.m. Sept. 19, 2014 - Zacks.com
Stock Market News for September 19, 2014 - Market News 10:10 a.m. Sept. 19, 2014 - Zacks.com
Merck (MRK) On Momo Momentum Watch Today 9:49 a.m. Sept. 19, 2014 - TheStreet.com
EC clears Xultophy 7:18 a.m. Sept. 19, 2014 - Seeking Alpha
Big Pharma Might Finally Be Over the Alzheimer’s Hump 5:32 a.m. Sept. 19, 2014 - InvestorPlace.com
Merck Enters into Licensing Agreement with Sun Pharma - Analyst Blog 4:55 p.m. Sept. 18, 2014 - Zacks.com
FDA clears Trulicity 4:03 p.m. Sept. 18, 2014 - Seeking Alpha
Roadmap Capital's Hugh Cleland And Stephen Ireland: Due Diligence Rules In Biotech Investment 3:08 p.m. Sept. 18, 2014 - Seeking Alpha
Bayer Moves Out of Material World 10:34 a.m. Sept. 18, 2014 - The Wall Street Journal Interactive Edition
Bayer to Seek Plastics IPO 8:44 a.m. Sept. 18, 2014 - The Wall Street Journal Interactive Edition
Credit Suisse Gold Standard Yield Stocks May Be the Safest to Own Now 7:20 a.m. Sept. 18, 2014 - 247WallSt.com
Rite Aid Stock a Sell on Deteriorating Fundamentals and Technicals 6:02 a.m. Sept. 18, 2014 - InvestorPlace.com
Merck Posts Positive Data on Osteoporosis Drug Odanacatib - Analyst Blog 7:15 p.m. Sept. 17, 2014 - Zacks.com
Roche CEO Rules Out Big Deals 10:29 a.m. Sept. 17, 2014 - The Wall Street Journal Interactive Edition
Merck once-weekly diabetes drug candidate successful in Phase 3 10:00 a.m. Sept. 17, 2014 - Seeking Alpha
Dow Jones (DJIA) Today: E I Du Pont De Nemours & Company (DD) Leads The Day Higher, Merck (MRK) Lags 10:00 a.m. Sept. 17, 2014 - TheStreet.com
Sun licenses Merck anti-inflammatory mAb 9:05 a.m. Sept. 17, 2014 - Seeking Alpha
Merck Presents First Phase 3 Data In Japanese Patients for Omarigliptin, An Investigational Once-Weekly DPP-4 Inhibitor For Type 2 Diabetes 8:34 a.m. Sept. 17, 2014 - benzinga.com
Bayer to Separate Plastics Unit 12:01 a.m. Sept. 17, 2014 - The Wall Street Journal Interactive Edition

Merck Animal Health to market Neogen's dairy genomic program 8:45 a.m. Sept. 18, 2014 - PR Newswire - PRF
Sun Pharma and Merck & Co. Inc. Enter into Licensing Agreement for Tildrakizumab 1:38 p.m. Sept. 17, 2014 - BusinessWire - BZX
Merck Presents First Phase 3 Data in Japanese Patients for Omarigliptin, an Investigational Once-Weekly DPP-4 Inhibitor for Type 2 Diabetes 9:32 a.m. Sept. 17, 2014 - BusinessWire - BZX
Sun Pharma and Merck & Co. Inc. Enter into Licensing Agreement for Tildrakizumab 8:30 a.m. Sept. 17, 2014 - BusinessWire - BZX
OncoSec Medical Expands Legal Team, Appoints Sheela Mohan-Peterson as General Counsel and Corporate Secretary 6:02 a.m. Sept. 17, 2014 - BusinessWire - BZX
Merck Announces Data from Pivotal Phase 3 Fracture Outcomes Study for Odanacatib, an Investigational Oral, Once-Weekly Treatment for Osteoporosis 1:30 p.m. Sept. 15, 2014 - BusinessWire - BZX
New Product Launch, Accelerated Drug Approvals, Study Initiation, and Market Activity - Research Reports on Johnson & Johnson, Merck, Medtronic, Pharmacyclics and NPS Pharma 9:15 a.m. Sept. 15, 2014 - PR Newswire - PRF
BeiGene Receives Clinical Milestone Payment for Development of BGB-290 8:00 a.m. Sept. 15, 2014 - BusinessWire - BZX
U.S. Northeast Remains Life-Science Darling, Attracting $8 Billion in Capital Investment, an Industrial Info News Alert 6:31 a.m. Sept. 11, 2014 - Marketwire
Merck & Co.'s Keytruda is Approved in the United States for the Treatment of Advanced and Unresectable Malignant Melanoma 10:00 a.m. Sept. 10, 2014 - PR Newswire - PRF
Animal Antimicrobials and Antibiotics Market by Products (Tetracyclines, Penicillins, Sulfonamides, Aminoglycosides), Animals (Dog, Poultry, Swine), Mode Of Delivery (Premixes, Oral Powders and Solutions, Injections) - Global Forecasts to 2018 8:48 p.m. Sept. 9, 2014 - PR Newswire - PRF
Animal Parasiticides Market by Product (Endoparasiticides, Ectoparasiticides, Endectocides, Oral Liquids, Tablets, Injectables, Sprays, Pour On, Spot On, Collars, Ear Tags), Animal (Dogs, Cats, Cattle, Pigs, Sheep & Goats) - Global Forecast to 2018 6:51 p.m. Sept. 9, 2014 - PR Newswire - PRF
Broccolini and Magil Laurentian announce the acquisition of the former Merck Canada complex in Kirkland, Quebec 3:08 p.m. Sept. 9, 2014 - PR Newswire - PRF
Global Hepatitis C Market 2014-2018 9:58 p.m. Sept. 8, 2014 - PR Newswire - PRF
Acucela Appoints Biotechnology Industry Veteran and Former Pharmaceutical Executive, Brian O’Callaghan, as Its New President and Chief Operating Officer and Interim CFO; Ryo Kubota, MD, PhD, to Remain in His Role as Chairman and CEO 8:15 p.m. Sept. 8, 2014 - BusinessWire - BZX
Merck to Participate at the Morgan Stanley Global Healthcare Conference 5:00 p.m. Sept. 8, 2014 - BusinessWire - BZX
Upcoming Presentations, Technical Update, Study Results, and Marketing Authorization Application - Research Reports on Novartis, InterMune, Johnson & Johnson, Amgen and Merck 9:00 a.m. Sept. 5, 2014 - PR Newswire - PRF
FDA Approves Pembrolizumab for Advanced Melanoma 5:07 p.m. Sept. 4, 2014 - PR Newswire - PRF
Merck Receives Accelerated Approval of KEYTRUDA® (pembrolizumab), the First FDA-Approved Anti-PD-1 Therapy 3:46 p.m. Sept. 4, 2014 - PR Newswire - PRF
MRA Applauds Latest Melanoma Drug Approval as “Major Breakthrough” 3:31 p.m. Sept. 4, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Investcorp's Strong 2026: A Deep Dive into Key Moves

Diving into Investcorp's Robust 2026 Performance If you're clued into the investment scene, you'll know that a $65.2 billion asset base isn't small potatoes. At the Gateway Gulf 2026, Investcorp didn't just present numbers—they laid out a dramatic year of action packed with billion-dollar dreams. While the dust hasn't quite settled yet, the first nine months of the year...

Immunic's November Moves: Conferences and Clinical Trials

Immunic Taps Into November Conferences Every now and then, you catch a company that's not just spinning its wheels but making some potentially big waves in their field. This time, it's Immunic, Inc. (Nasdaq: IMUX), stepping into the spotlight. They're strutting their stuff at several investor conferences this November, starting with Boston and New York, then hopping over...

MetaOptics Expands U.S. Reach with ADR Programme

A Bold Move into the U.S. Market MetaOptics Ltd, the semiconductor optics dynamo out of Singapore, is kicking up some investment dust with their American Depositary Receipts (ADR) Programme aimed squarely at expanding its U.S. footprint. And let me tell you, in the game of international market expansion, that's no rookie maneuver. Why ADR? Why Now? So, why is MetaOptics...

Ascletis Showcases Bold Moves in Obesity Drug Arena

If you’ve been watching the developments in the world of obesity treatments, Ascletis Pharma is a name you'd do well not to ignore. With ObesityWeek 2026 on the horizon, these folks aren’t just talking—they’re putting their preclinical cards on the table and they’re noteworthy. Unveiling Future Contenders Ascletis is gearing up to present some of their...

Check Point Q3 2026 Results: Subtle Shifts or a Turning Point?

Digging Deeper into Check Point's Latest Figures When Check Point Software Technologies Ltd. (NASDAQ:CHKP) throws numbers at the wall, not everything sticks, but there's always something telling. The Q3 financial results for 2026 are out, and it's a mixed bag—coffee’s getting cold before you parse through it. Revenue and Subscription Dynamics Let's cut to it: total...

Blokees Joins 'MIKU WITH YOU 2026' Concert in China

Blokees Partners with Iconic Virtual Star Hatsune Miku There's a new player cozying up in the world of virtual icons, and it's none other than Blokees. If you haven't heard, Blokees just dipped its toes into the buzzing waters of the Hatsune Miku fandom by becoming an official strategic partner at the 'MIKU WITH YOU 2026' concert in Shanghai. You could call this a step up...

ElektraFi Challenges Starlink: Fixed Wireless Gains Edge

Revolution or Just Better Options? In the wild west of internet connectivity, where every home is a frontier, ElektraFi is throwing down the gauntlet at the feet of behemoths like Starlink. They're talking big about their fixed wireless network, and in places stretching from Colorado's ski slopes to the dustier reaches of Texas, that talk might just hold some weight. Why...

Maritime Launch Takes Flight with TSX Listing

Turning Point for Maritime Launch Services It's a new dawn for Maritime Launch Services, folks. They're gearing up to list on the Toronto Stock Exchange (TSX) come November 3, under the ticker "MAXQ." It’s like they're strapping rockets to their business model, and it ain’t just for show. A Strategic Move with High Hopes Listing on the TSX isn’t a mere vanity...

ENGWE Unleashes Massive Black Friday E-Bike Discounts

ENGWE Powers Up the 2026 Black Friday Storm If you’ve ever been on the hunt for a reliable e-bike, ENGWE is making a racket that’ll be impossible to ignore this Black Friday. Starting November 2nd and running up to December 3rd, they’re throwing down the gauntlet with some jaw-dropping deals across their line-up. Now, why should you care? For starters, they’ve...

Aiper’s Black Friday Pool Deals Make a Splash

Black Friday: A Pool Owner's Break It’s not every day you stumble upon savings like these—Aiper is throwing some meaty discounts this Black Friday, saving pool owners up to a juicy $550 off robotic cleaners. Imagine that! For anyone with a pool to maintain, these deals might just be the ticket to less grunt work and more time lounging with a cold drink in hand....